AGP Picks
View all

Alercell adds Jason Yager to advisory board

5 hours ago
Alercell adds Jason Yager to advisory board

By AI, Created 12:01 AM UTC, May 27, 2026, /AGP/ – Alercell named Montana Photonics & Quantum Alliance Executive Director Jason A. Yager to its Advisory Board as the Bozeman precision oncology company builds out its Montana operations. The move is meant to strengthen workforce, ecosystem and public-sector ties ahead of the planned opening of Alercell’s flagship clinic in the coming months.

Why it matters: - Alercell is leaning on a Montana deep-tech leader as it scales a precision oncology platform tied to the state’s science, workforce and policy ecosystem. - The appointment comes as the company prepares for the planned opening of its flagship precision oncology clinic in Bozeman in the coming months. - Alercell is also working within a Montana-based Phase-1-to-Patient Pathway under SB 535, making local coordination a core part of its operating plan.

What happened: - Alercell, Inc. appointed Jason A. Yager to its Advisory Board on May 27, 2026. - Yager will advise Alercell on Montana ecosystem integration, workforce development and public-sector alignment. - Alercell is headquartered in Bozeman, Montana. - The company is developing the LENA Platform, an AI-powered epigenetic diagnostic system for the pre-symptomatic detection of hematologic malignancies.

The details: - Frederic Scheer, Alercell’s founder, chairman and chief executive officer, said the company’s path runs through Montana and that the LENA Platform was validated in the state. - Scheer said the flagship clinic will be built in Montana and linked the company’s regulatory strategy to SB 535. - Yager is the Executive Director of the Montana Photonics & Quantum Alliance. - Yager also serves on the Montana Chamber Foundation Board and the Montana State Workforce Innovation Board. - Yager advises Montana State University’s Gallatin College on its Laser and Photonics Technology Program. - Before joining the alliance, Yager held senior operations and commercial leadership roles at Lumibird, formerly Quantel Laser, and at Vision Aerial. - Yager led manufacturing scale-up and international commercialization of precision laser and unmanned aerial systems. - Yager earned a Master of Science in Physics and a Bachelor of Science in Physics from Montana State University. - Alercell says the LENA Platform has been validated across more than 199,000 electronic medical records. - Alercell is pursuing a two-rail regulatory strategy with near-term commercialization through CLIA-based laboratory-developed tests and FDA De Novo authorization as a longer-term goal. - Alercell was founded in June 2020. - More information is available at the company’s website.

Between the lines: - The board appointment signals that Alercell wants more than scientific validation; it wants local institutional support to recruit talent, navigate state-level relationships and scale operations in Montana. - Yager’s background in photonics, manufacturing and commercialization fits a company that is trying to move from platform development toward clinical and operational execution. - The release also positions Alercell as part of Montana’s broader deep-tech identity, not just a standalone healthcare startup.

What’s next: - Alercell expects to open its flagship precision oncology clinic in the coming months. - The company will continue building its Bozeman operations while advancing its CLIA and FDA regulatory paths. - Yager’s role on the Advisory Board is likely to focus on workforce development and ecosystem-building as those milestones approach.

The bottom line: - Alercell is adding a Montana technology ecosystem insider to help turn its local scientific ambitions into an operating business with clinic, workforce and regulatory infrastructure in place.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

The Helena Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

The Helena Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.